While an admirable goal, it can be challenging for consumers to determine where a product is made based solely on its ...

The Company expects that its cash resources at December 31, 2024, and the gross proceeds of approximately $30.4 million raised from sales under its at-the-market facility in the first quarter of 2025, ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

Andrew Taake received a six-year sentence for assaulting officers on Jan. 6. He was arrested Thursday on an outstanding ...

A thick cloud of smoke rolled slowly across Middleton on Thursday morning as fire burned in a vacant building in the downtown ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

The world of artificial intelligence had a rude awakening over the winter. Towards the end of January, a Chinese chatbot ...

Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...

Hydreight Technologies Inc. (“Hydreight”or the “Company”)(TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6), a fast-growing mobile clinical network and medical platform which ...

Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with U.S. FDA PDUFA goal date of August 15, 2025 ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...